Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Baxter
Boehringer Ingelheim
Merck
McKinsey

Last Updated: June 29, 2022

PROVENTIL-HFA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Proventil-hfa, and when can generic versions of Proventil-hfa launch?

Proventil-hfa is a drug marketed by Kindeva and is included in one NDA.

The generic ingredient in PROVENTIL-HFA is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Proventil-hfa

A generic version of PROVENTIL-HFA was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.

  Try it Free

Drug patent expirations by year for PROVENTIL-HFA
Recent Clinical Trials for PROVENTIL-HFA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AstraZenecaPhase 2
University Medical Center of Southern NevadaN/A
West Penn Allegheny Health SystemPhase 4

See all PROVENTIL-HFA clinical trials

Pharmacology for PROVENTIL-HFA
Paragraph IV (Patent) Challenges for PROVENTIL-HFA
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PROVENTIL-HFA Inhalation Aerosol albuterol sulfate 0.09 mg base per actuation 020503 1 2015-05-20

US Patents and Regulatory Information for PROVENTIL-HFA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503-001 Aug 15, 1996 AB1 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PROVENTIL-HFA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503-001 Aug 15, 1996 See Plans and Pricing See Plans and Pricing
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503-001 Aug 15, 1996 See Plans and Pricing See Plans and Pricing
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503-001 Aug 15, 1996 See Plans and Pricing See Plans and Pricing
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503-001 Aug 15, 1996 See Plans and Pricing See Plans and Pricing
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503-001 Aug 15, 1996 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PROVENTIL-HFA

See the table below for patents covering PROVENTIL-HFA around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 0673857 Dispositif d'émission d'un aérosol (Device for delivering an aerosol) See Plans and Pricing
European Patent Office 0653204 Formulations d'aérosols à usage médical (Medicinal aerosol formulations) See Plans and Pricing
Japan H02200627 MEDICAL AEROSOL PREPARATION See Plans and Pricing
Hong Kong 80497 Medicinal aerosol formulations See Plans and Pricing
Denmark 0673857 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
McKinsey
Boehringer Ingelheim
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.